>>>>MUST READ COURTESY OF HOKIE

New Post Public Reply Private Reply Replies (1) Message Board
MoneyMaker
>>>>MUST READ COURTESY OF HOKIE<<<<

RXSF - Stock of 2016..

 

Current PPS: $2.67

HokieHead's Projected PPS: $75.00

 



 

 

About RXSF :

 RX Safes designs,develops, engineers, and markets fingerprint medical security storage solutionsfor consumers and healthcare professionals, using a common, patented,autonomous fingerprint interface which offers heightened security, tightercontrols and greater convenience. The company's products offer safety andsecurity of prescription medications and other controlled substances in thehome, within commercial healthcare facilities and out in the field.Prescription Drugs are more deadly than car accidents and guns combined andkill more than 100 people each day in the U.S. With a social and economic pricetag of over $600 billion, the company is dedicated to providing comprehensivesolutions to address the issues caused by drug diversion and unauthorizedaccess to these medications, with products ranging from fingerprint medicationsafes, portable medical storage solutions PCA pendants, needle-free injectors,locks and portable HIPAA compliant EHRs.

 

http://www.rxdrugsafe.com/

 

Share Structure (per OTC Markets) :

 Market: OTCQB

 Shares Outstanding:1,467,498

 Shares Floating:283,025

 Floating Shares ownedby Insiders: 175,000+

 Market Cap @ $2.67 =$3.9 million

 

 

 

 

 



Recent Executive Summary and InvestorPresentation :

 

http://www.rxdrugsafe.com/files/Rx%20Safes%20...ressed.pdf

 

http://www.rxdrugsafe.com/files/Executive%20S...ressed.pdf

 

Slide 24/27 - $25 million investment results in 3years:

 -$95 million revenues

 -$27 million cash onhand

 -$43 million EBITDA

 

 

Medical Device Research Analyst 12/21/15: Target:$17  

 

http://rxdrugsafe.com/files/Rx%20Safes%20Inc%...iation.pdf

 

 

Company introduces 2016 Growth Plans :

 

http://www.rxdrugsafe.com/rx-safes-releases-s...-letter-2/

 

 

In 2016 I am expecting the following here:  

 

 1. BankFinancing - Non toxic bank loan, possibly in installments, starting inthe $2.5 million range, up to a possible $25 million in 2016.

 2. FutureConvertible Debt - With bank financing, CD's coming due in a few monthswill be paid off, leaving zero potential of additional shares.

 3. StockExchange Uplist - Within 1-2 months the company will meet all therequirements to uplist to the NYSE/NASDAQ exchange.

 4. CreateCompany Synergies - Partner with manufacturers, like Mika Medical, thatwill keep costs down and improve gross margins.

 5. ExpandRxSafe Programs - With the success of the Online CVS program, expandthe sales to CVS stores and even more pharmacies and brick/mortar departmentstores. Possible safe sales of over 150,000 safes in 2016, or $15 million insales.

 6. ProfessionalHealthcare Products - Per PR 11/12/15, partner with infusion pumpmanufacturers to include RX SafeDose and RX MyDose. BIG BUCKS.

 7. Sales ofother (new) products - Added sales from RXSFs other ProfessionalHealthcare products and any other new items under development the pubic isn'taware of.

 8. Possiblebuyout candidate - The patents, technology and products RXSF offerswould be a tempting company to be acquired by a large Medical Device or PharmaCompany with tons of cash. Dropping $100 million + for this company within ayear is not out of the question.

 

 

So what could RXSF look like as far as numbers within 1-2years:

 

Revenues: $75.0 million

 Expenses: $60.0million

 Income: $15.0 million

 Outstanding Shares: 10.0 million (increased outstanding figure to include financing shares)

 

 P/S Ratio (IndustryAverage 3): $75.0 million x 10 = $750 million / 10.0 million = $75 price pershare

 

 P/E Ratio (IndustryAverage 32): $15.0 million / 10 million = $1.50 x 50 = $75 price pershare

 

 $1,000 investment01/2016 = $27,000 possible value within a year

 

 Comments: I used theP/S Ratio of 10 and a PE Ratio of 50, higher than the industry averages due tothe higher than expected growth rate for RXSF. I also used a conservativeincome figure. See you on NYSE or Nasdaq over $50 a share unless we get boughtout first.

GeneSYS ID, Inc. (GNID) Stock Research Links

GNID Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Davos Healthcare Aims to Revolutionize Hospital Ratings

Updated Category News Views 7

Throw away those dusty, old reputation surveys—Davos Healthcare just turned the spotlight onto cold, hard data with its new global hospital evaluation platform. Why Davos Healthcare’s Initiative Matters At the C3 US NYC Davos of Healthcare™ Summit, an event that’s rooted itself alongside the United Nations General Assembly, Davos Healthcare unveiled a...

Continue Reading
AI-Driven Lumi Transforms Car Dealership Interactions

Updated Category News Views 8

Lumi: Changing the Car Buying Game Picture this: You're browsing for a new car, head filled with specifics like towing capacity, price points, and trim options. Usually, such queries would send you bouncing around the web, but Lectrium's Lumi promises to keep the questioning—and decision-making—right on the dealership's page. In a move set to shake up the game,...

Continue Reading
K-Beauty Takes Front Stage at Target Beauty Studio

Updated Category News Views 7

Making Waves in the U.S. with K-Beauty SUNGBOON EDITOR and Milk Touch just rolled into Target Beauty Studio, making a splash in the world of K-beauty. From ingredients that boast serious benefits to playful cosmetics that let you express yourself, these brands are shaking up American beauty routines in a big way. Ingredient-Focused Skincare for Every American Face...

Continue Reading
The Chemical Industry and EPA: A Broken System?

Updated Category News Views 6

Decades of an Unchecked Revolving Door The Environmental Protection Agency (EPA) and chemical manufacturers—a dance that’s been going on for what seems like forever. But not in the way you might hope. We're talking about a revolving door where execs and lobbyists waltz into regulatory chairs while regulators slide into cushy industry gigs. Wisner Baum LLP, a stickler...

Continue Reading
Succession Planning in Turmoil: Only 42% Ready

Updated Category News Views 8

Diving into the Succession Crisis in Finance Succession planning in the financial advisory space is like retirement planning for the rest of us—everyone knows it's crucial, yet too many put it off. Despite the looming retirement wave and desperate interest from the younger cohort, a staggering 42% of financial advisors are still without a documented succession game...

Continue Reading
HTX's Strategic Moves in Pakistan: A Crypto Frontier

Updated Category News Views 7

Paving the Way: HTX's Journey in Pakistan Rolling into the Pakistan cryptocurrency scene isn't just a 'walk in the park' for HTX—it's more like traversing a new frontier with an open map. This isn’t some hit-and-run operation; HTX is strategizing for a long haul in one of the liveliest digital market arenas in South Asia. Gathering steam with community AMAs and an X...

Continue Reading
Compass Unveiled: Power Revolution in Private Equity

Updated Category News Views 8

AI-Driven Insights: Revolutionizing Private Equity Strategies Now this is some spicy news from Huntington Beach! Collective just pulled back the curtain on Compass, their AI-fueled platform that's set to shake up how financial advisors tackle private company equity. If you're an advisor who's sick of staring at nebulous balance sheets filled with unquantifiable private...

Continue Reading
Dr. Desi Bartlett Teams Up with Glo for Perimenopause Focus

Updated Category News Views 4

Glo Taps Top Wellness Expert for Women's Health Initiative In an industry brimming with wellness voices, it's rare to find one that marries scholarly acumen with authentic, personal teaching. Yet, this is precisely what Dr. Desi Bartlett brings to the table as she partners with Glo to offer new fitness programming specifically targeting women facing perimenopause and...

Continue Reading
Leapora's Taskeen: Redefining Task Accountability

Updated Category News Views 8

AI's Impact on Workplace Task Management In today’s whirlwind of AI-generated output, transparency is not just a luxury; it’s a necessity. AI systems churn out work that can appear polished but often lacks substance. This doesn't just create headaches; it triggers a ticking bomb in the regulatory department. According to a 2025 survey from Stanford and BetterUp Labs,...

Continue Reading
Sean Trahan Joins Citrin Cooperman: New Tax Lead

Updated Category News Views 11

Citrin Cooperman's Strategic Tax Move If there's one phrase that can spark a debate at a financial water cooler, it's 'transfer pricing.' Today, Citrin Cooperman is throwing its hat further into that ring with the appointment of Sean Trahan as head of their new Transfer Pricing and Value Chain Optimization Practice. This isn't just another reshuffling of office...

Continue Reading

Top 5 Most Recently Viewed Articles

Nonfarm Payrolls Data Shows Remarkable Job Growth and Impact

Updated Category News Views 346

Understanding the Impact of Nonfarm Payrolls Report The latest statistics from the Nonfarm Payrolls report have presented some eye-opening results in employment figures. The total number of employed individuals, excluding agriculture and certain other employment sectors, has shot up to 256,000. This number has not only exceeded expectations but has also painted a brighter...

Continue Reading
WuXi Biologics Achieves Remarkable Growth in 2025 Results

Updated Category News Views 768

WuXi Biologics Reports Impressive Interim Results WuXi Biologics (stock code: 2269.HK), a prominent global Contract Research, Development and Manufacturing Organization (CRDMO), has showcased robust performance in its interim results for the first half of 2025. The data released illustrates a remarkable 16.1% year-over-year increase in revenue, reaching a significant RMB...

Continue Reading
Trulieve Takes a Major Step Forward with Texas License

Updated Category News Views 165

Trulieve Cannabis Corp. Receives Conditional Approval in Texas Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF), a prominent leader in the cannabis industry, is thrilled to announce that it has received conditional approval for a Dispensing Organization license from the Texas Department of Public Safety. This significant milestone allows Trulieve TX, Inc. to engage in...

Continue Reading
Alliance Witan PLC Updates on Net Asset Value Insights

Updated Category News Views 42

Understanding Alliance Witan PLC's Net Asset Value Alliance Witan PLC is notable in the investment management arena, focusing on delivering substantial long-term returns. Investors pay close attention to the company's Net Asset Value (NAV) as it gives insights into the company’s financial health and asset valuation. Recently, Alliance Witan PLC provided an update...

Continue Reading
Unleashing Versatility: Getac's B360 and B360 Pro Laptops

Updated Category News Views 133

Introducing Getac's Advanced B360 and B360 Pro Laptops Getac Technology Corporation has officially launched the next generation of rugged laptops, the B360 and B360 Pro. These devices are engineered to withstand the toughest conditions while offering advanced AI-ready technology. Featuring the latest Intel® Core Ultra Series 2 processors and Intel® AI Boost technology,...

Continue Reading